Two years ago, the Opposites Attract study found no transmissions between 343 regular gay couples of differing HIV status where the HIV-positive partner had a viral load under 200 copies/ml, the ...

New data presented at the 13th International AIDS Society Conference on HIV Science (IAS 2025) yesterday show that two long-acting injectable PrEP options, lenacapavir and cabotegravir, are safe, well ...

There have been no definite cases of HIV infection among healthcare workers following an occupational needlestick injury in the UK since 1999.

Having an undetectable viral load means that there is not enough of the virus in body fluids to pass on HIV during sex. This is sometimes referred to as 'U=U'.

The British HIV Association (BHIVA) has recommended that everyone living with HIV aged 40 and over should take a statin to reduce their risk of heart disease, even if they do not have raised ...

The chance of any HIV-positive person with an undetectable viral load transmitting the virus to a sexual partner is scientifically equivalent to zero, researchers confirmed at the 22nd International ...

The majority of South African HIV patients could be switched to the World Health Organization’s recommended first-line regimen if the country adopts advice from leading doctors. This would allow most ...

Once again, a life expectancy study has shown that HIV-positive people who start antiretroviral therapy (ART) promptly and have good access to medical care live as long as their HIV-negative peers.

A study from South Africa and Malawi published online ahead of print in Clinical Infectious Diseases highlights the urgent need for better management of people with TB and HIV co-infection. It shows ...

Doxycycline post-exposure prophylaxis (doxyPEP), which was found to be highly effective at preventing sexually transmitted infections (STIs) among gay men and transgender women, did not protect young ...

Differences in the performance of commonly used HIV tests lead to substantial differences in the number of infections which are diagnosed in everyday clinical practice, according to an analysis from ...

It’s rare in any branch of medicine that a trial of a new drug can report 100% efficacy, and a first in HIV science. But that’s what happened on Friday, when Gilead Sciences announced that no HIV ...